BCL2 and cancer: In line with previous reports in alternative cancer cohorts12,22, genomic gains of MCL-1 occurred at higher frequency than any other BCL-2 family member and did not cause compensatory deregulation of other BCL-2 protein family members, as detected in the TCGA and TRACERx datasets.